SOST and chronic kidney disease: Across the entire CKD cohort, the median of sclerostin was 52.6 pmol/L, which was above that of our healthy controls (median (IQR) of 36.7 (28.4, 48.3) pmol/L with a range of 12.4–93.2 pmol/L).